A Worldwide Recognized Antimalarial for Severe and Complicated Malaria

In the 1980s, KPC worked with research institutions including Institute of Materia Medica (IMM) to develop a groundbreaking innovative antimalarial drug based on artemisinin - Artemether Injection. Artemether Injection is included in the WHO Model Lists of Essential Medicines, WHO Guidelines for the treatment of malaria and the procurement list of UNICEF.